• Nursing Insights on the Management of Patients with ALL/LBL Treated with Asparaginase Therapy
  • Frontline Treatment of DLBCL: Practice Implications
  • Treating Relapsed/Refractory DLBCL: Practice Implications
  • Addressing Disparities in Care for Patients with DLBCL
  • Faculty Roundtable on CAR T-cell Therapies, Bispecific Antibodies & Antibody-Drug Conjugates in FL
  • Advances and Evolving Standards of Care in Transplant-ineligible NDMM
  • Spotlight on Relapsed/Refractory Follicular Lymphoma
  • Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma
  • New Directions in the Frontline Treatment of DLBCL: Implications for Practice
  • New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice
  • Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice
  • Addressing Disparities in Care for Patients with DLBCL
  • Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings

What's New

CE for Nurses
Nursing Insights on the Management of Patients with ALL/LBL Treated with Asparaginase Therapy
Sandra Kurtin, PhD, ANP-C, AOCN, FAPO
Newsletter
Frontline Treatment of DLBCL: Practice Implications
Andrew D. Zelenetz, MD, PhD
Newsletter
Treating Relapsed/Refractory DLBCL: Practice Implications
Matthew Lunning, DO, FACP
Newsletter
Addressing Disparities in Care for Patients with DLBCL
Loretta J. Nastoupil, MD
CE Education
Faculty Roundtable on CAR T-cell Therapies, Bispecific Antibodies and Antibody-Drug Conjugates in Follicular Lymphoma
Loretta J. Nastoupil, MD and Catherine S. Diefenbach, MD
CE Education
Spotlight on Relapsed/Refractory Follicular Lymphoma
James O. Armitage, MD; and Reid W. Merryman, MD
CE Education
Improving the Spectrum of Care for Patients with Diffuse Large B-cell Lymphoma
James O. Armitage, MD; John P. Leonard, MD; and Jason Westin, MD, MS, FACP
CE Education
New Directions in the Frontline Treatment of DLBCL: Implications for Practice
James O. Armitage, MD; and Andrew D. Zelenetz, MD, PhD
CE Education
Current and Emerging Directions in the Frontline Treatment of Follicular Lymphoma: Implications for Practice
James O. Armitage, MD; and Gilles Salles, MD, PhD
CE Education
New Directions in the Treatment of Relapsed/Refractory DLBCL: Implications for Practice
James O. Armitage, MD; and Matthew Lunning, DO, FACP
CE Education
Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Elizabeth Griffiths, MD, and Ilene C. Weitz, MD
CE Education
Addressing Disparities in Care for Patients with DLBCL
James O. Armitage, MD; and Loretta J. Nastoupil, MD
CE Education
Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings
Joshua Richter, MD